| 3701 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2021 |
Standard Therapy |
Poland |
56 |
| 3702 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2021 |
Standard Therapy |
Poland |
46 |
| 3703 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2021 |
Standard Therapy |
Poland |
3 |
| 3704 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2021 |
Standard Therapy |
Poland |
25 |
| 3705 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2021 |
Standard Therapy |
Poland |
53 |
| 3706 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2021 |
Standard Therapy |
Poland |
61 |
| 3707 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2021 |
Standard Therapy |
Poland |
51 |
| 3708 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2021 |
Standard Therapy |
Poland |
50 |
| 3709 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2021 |
Standard Therapy |
Poland |
62 |
| 3710 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2021 |
Standard Therapy |
Poland |
69 |
| 3711 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2021 |
Standard Therapy |
Poland |
35 |
| 3712 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2021 |
Standard Therapy |
Poland |
68 |
| 3713 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2021 |
Standard Therapy |
Poland |
14 |
| 3714 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2021 |
Standard Therapy |
Poland |
49 |
| 3715 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2021 |
Standard Therapy |
Poland |
80 |
| 3716 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2021 |
Standard Therapy |
Poland |
66 |
| 3717 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2021 |
Standard Therapy |
Poland |
31 |
| 3718 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2021 |
Standard Therapy |
Poland |
32 |
| 3719 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2021 |
Standard Therapy |
Poland |
61 |
| 3720 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2021 |
Standard Therapy |
Poland |
64 |
| 3721 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2021 |
Standard Therapy |
Poland |
10 |
| 3722 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2021 |
Standard Therapy |
Poland |
67 |
| 3723 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2021 |
Standard Therapy |
Poland |
57 |
| 3724 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2021 |
Standard Therapy |
Poland |
55 |
| 3725 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2021 |
Standard Therapy |
Poland |
68 |
| 3726 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2021 |
Standard Therapy |
Poland |
61 |
| 3727 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2021 |
Standard Therapy |
Poland |
17 |
| 3728 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2021 |
Standard Therapy |
Poland |
46 |
| 3729 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2021 |
Standard Therapy |
Poland |
34 |
| 3730 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2021 |
Standard Therapy |
Poland |
39 |
| 3731 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2021 |
Standard Therapy |
Poland |
53 |
| 3732 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2021 |
Standard Therapy |
Poland |
63 |
| 3733 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2021 |
Standard Therapy |
Poland |
22 |
| 3734 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2021 |
Standard Therapy |
Poland |
56 |
| 3735 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2021 |
Standard Therapy |
Poland |
42 |
| 3736 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2021 |
Standard Therapy |
Poland |
66 |
| 3737 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2021 |
Standard Therapy |
Poland |
52 |
| 3738 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2021 |
Standard Therapy |
Poland |
13 |
| 3739 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2021 |
Standard Therapy |
Germany |
32 |
| 3740 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2021 |
Standard Therapy |
Germany |
61 |
| 3741 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2021 |
Standard Therapy |
Germany |
72 |
| 3742 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2021 |
Standard Therapy |
Germany |
55 |
| 3743 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2021 |
Standard Therapy |
Germany |
57 |
| 3744 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2021 |
Standard Therapy |
Germany |
62 |
| 3745 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2021 |
Standard Therapy |
Germany |
46 |
| 3746 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2021 |
Standard Therapy |
Germany |
63 |
| 3747 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2021 |
Standard Therapy |
Germany |
65 |
| 3748 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2021 |
Standard Therapy |
Germany |
71 |
| 3749 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2021 |
Standard Therapy |
Germany |
53 |
| 3750 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2021 |
Standard Therapy |
Germany |
57 |
| 3751 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2021 |
Standard Therapy |
Germany |
50 |
| 3752 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2021 |
Standard Therapy |
Germany |
32 |
| 3753 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2021 |
Standard Therapy |
Germany |
71 |
| 3754 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia – Relapse |
Hematology |
2021 |
Standard Therapy |
Germany |
65 |
| 3755 |
Apheresis |
Autologous |
Amyloidosis |
Hematology |
2021 |
Standard Therapy |
Germany |
63 |
| 3756 |
Apheresis |
Allogeneic |
Anaplastic Large Cell Lymphoma |
Hematology |
2021 |
Standard Therapy |
Germany |
56 |
| 3757 |
Apheresis |
Autologous |
Angioimmunoblastic T-Cell Lymphoma |
Hematology |
2021 |
Standard Therapy |
Germany |
62 |
| 3758 |
Apheresis |
Allogeneic |
Aplastic Anemia |
Hematology |
2021 |
Standard Therapy |
Poland |
54 |
| 3759 |
Apheresis |
Allogeneic |
Aplastic Anemia |
Hematology |
2021 |
Standard Therapy |
Poland |
7 |
| 3760 |
Apheresis |
Allogeneic |
Aplastic Anemia |
Hematology |
2021 |
Standard Therapy |
Poland |
40 |
| 3761 |
Apheresis |
Allogeneic |
Aplastic Anemia |
Hematology |
2021 |
Standard Therapy |
Poland |
14 |
| 3762 |
Apheresis |
Allogeneic |
B-Cell Acute Lymphoblastic Leukemia |
Hematology |
2021 |
Standard Therapy |
Poland |
36 |
| 3763 |
Apheresis |
Autologous |
B-Cell Lymphoma |
Hematology |
2021 |
Standard Therapy |
Germany |
59 |
| 3764 |
Apheresis |
Autologous |
B-Cell Lymphoma |
Hematology |
2021 |
Standard Therapy |
Germany |
33 |
| 3765 |
Apheresis |
Autologous |
B-Cell Lymphoma |
Hematology |
2021 |
Standard Therapy |
Germany |
63 |
| 3766 |
Apheresis |
Autologous |
B-Cell Lymphoma |
Hematology |
2021 |
Standard Therapy |
Germany |
49 |
| 3767 |
Apheresis |
Allogeneic |
Chronic Granulomatous Disease |
Hematology |
2021 |
Standard Therapy |
Poland |
28 |
| 3768 |
Apheresis |
Allogeneic |
Chronic Granulomatous Disease |
Hematology |
2021 |
Standard Therapy |
Poland |
11 |
| 3769 |
Apheresis |
Allogeneic |
Chronic Lymphocytic Leukemia |
Hematology |
2021 |
Standard Therapy |
Poland |
62 |
| 3770 |
Apheresis |
Allogeneic |
Chronic Lymphocytic Leukemia |
Hematology |
2021 |
Standard Therapy |
Poland |
60 |
| 3771 |
Apheresis |
Allogeneic |
Chronic Lymphocytic Leukemia |
Hematology |
2021 |
Standard Therapy |
Poland |
63 |
| 3772 |
Apheresis |
Allogeneic |
Chronic Myelogenous Leukemia |
Hematology |
2021 |
Standard Therapy |
Poland |
52 |
| 3773 |
Apheresis |
Allogeneic |
Chronic Myelogenous Leukemia |
Hematology |
2021 |
Standard Therapy |
Poland |
45 |
| 3774 |
Apheresis |
Allogeneic |
Chronic Myelogenous Leukemia |
Hematology |
2021 |
Standard Therapy |
Poland |
37 |
| 3775 |
Apheresis |
Allogeneic |
Chronic Myelogenous Leukemia |
Hematology |
2021 |
Standard Therapy |
Poland |
62 |
| 3776 |
Apheresis |
Allogeneic |
Chronic Myelogenous Leukemia |
Hematology |
2021 |
Standard Therapy |
Poland |
64 |
| 3777 |
Apheresis |
Allogeneic |
Chronic Myelogenous Leukemia |
Hematology |
2021 |
Standard Therapy |
Poland |
74 |
| 3778 |
Apheresis |
Allogeneic |
Chronic Myelogenous Leukemia |
Hematology |
2021 |
Standard Therapy |
Poland |
31 |
| 3779 |
Apheresis |
Allogeneic |
Chronic Myelogenous Leukemia |
Hematology |
2021 |
Standard Therapy |
Poland |
63 |
| 3780 |
Apheresis |
Allogeneic |
Chronic Myelogenous Leukemia |
Hematology |
2021 |
Standard Therapy |
Poland |
18 |
| 3781 |
Apheresis |
Allogeneic |
Chronic Myelomonocytic Leukemia |
Hematology |
2021 |
Standard Therapy |
Poland |
68 |
| 3782 |
Apheresis |
Allogeneic |
Chronic Myelomonocytic Leukemia |
Hematology |
2021 |
Standard Therapy |
Poland |
59 |
| 3783 |
Apheresis |
Allogeneic |
Chronic Myelomonocytic Leukemia |
Hematology |
2021 |
Standard Therapy |
Poland |
67 |
| 3784 |
Apheresis |
Allogeneic |
Chronic Myelomonocytic Leukemia |
Hematology |
2021 |
Standard Therapy |
Poland |
62 |
| 3785 |
Apheresis |
Allogeneic |
Chronic Myelomonocytic Leukemia |
Hematology |
2021 |
Standard Therapy |
Poland |
34 |
| 3786 |
Apheresis |
Allogeneic |
Chronic Myelomonocytic Leukemia |
Hematology |
2021 |
Standard Therapy |
Poland |
70 |
| 3787 |
Apheresis |
Allogeneic |
Chronic Myelomonocytic Leukemia |
Hematology |
2021 |
Standard Therapy |
Poland |
71 |
| 3788 |
Apheresis |
Allogeneic |
Chronic Neutrophilic Leukemia |
Hematology |
2021 |
Standard Therapy |
Germany |
67 |
| 3789 |
Apheresis |
Allogeneic |
Diffuse Large B-Cell Lymphoma |
Hematology |
2021 |
Standard Therapy |
Poland |
62 |
| 3790 |
Apheresis |
Allogeneic |
Diffuse Large B-Cell Lymphoma |
Hematology |
2021 |
Standard Therapy |
Poland |
50 |
| 3791 |
Apheresis |
Autologous |
Diffuse Large B-Cell Lymphoma |
Hematology |
2021 |
Standard Therapy |
Germany |
68 |
| 3792 |
Apheresis |
Autologous |
Diffuse Large B-Cell Lymphoma |
Hematology |
2021 |
Standard Therapy |
Germany |
63 |
| 3793 |
Apheresis |
Autologous |
Diffuse Large B-Cell Lymphoma – Relapse |
Hematology |
2021 |
Standard Therapy |
Germany |
65 |
| 3794 |
Apheresis |
Autologous |
Diffuse Large B-Cell Lymphoma – Relapse |
Hematology |
2021 |
Standard Therapy |
Germany |
65 |
| 3795 |
Apheresis |
Autologous |
Diffuse Large B-Cell Lymphoma – Relapse |
Hematology |
2021 |
Standard Therapy |
Germany |
71 |
| 3796 |
Apheresis |
Allogeneic |
Farber Disease |
Hematology |
2021 |
Standard Therapy |
Poland |
9 |
| 3797 |
Apheresis |
Allogeneic |
Follicular Lymphoma |
Hematology |
2021 |
Standard Therapy |
Poland |
54 |
| 3798 |
Apheresis |
Autologous |
Follicular Lymphoma |
Hematology |
2021 |
Standard Therapy |
Germany |
55 |
| 3799 |
Apheresis |
Autologous |
Follicular Lymphoma |
Hematology |
2021 |
Standard Therapy |
Germany |
64 |
| 3800 |
Apheresis |
Autologous |
Follicular Lymphoma |
Hematology |
2021 |
Standard Therapy |
Germany |
50 |